Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000352998

Medchemexpress LLC Fatostatin hydrobromide | 298197-04-3 | MFCD00760867 | 99.52% | C18H19BrN2S | 25 MG
SDP

Catalog No. 5000352998
Encompass_Preferred

Fatostatin hydrobromide (125B11 hydrobromide) is a specific inhibitor of SREBP activation. It impairs the activation of SREBP-1 and SREBP-2 by binding to SCAP (SREBP cleavage-activating protein), which inhibits the ER-Golgi translocation of SREBPs. This action leads to a decrease in the transcription of lipogenic genes in cells.

  • Specific inhibitor of SREBP activation.
  • Impairs activation of SREBP-1 and SREBP-2.
  • Inhibits ER-Golgi translocation of SREBPs.
  • Decreases transcription of lipogenic genes.
  • Exhibits antitumor properties.
  • Lowers hyperglycemia in ob/ob mice.

Catalog No. 50-003-52998 Supplier Medchemexpress LLC Supplier No. 25MGHY14452A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Fatostatin hydrobromide (125B11 hydrobromide) is a specific inhibitor of SREBP activation. It impairs the activation of SREBP-1 and SREBP-2 by binding to SCAP (SREBP cleavage-activating protein), which inhibits the ER-Golgi translocation of SREBPs. This action leads to a decrease in the transcription of lipogenic genes in cells.

  • Specific inhibitor of SREBP activation.
  • Impairs activation of SREBP-1 and SREBP-2.
  • Inhibits ER-Golgi translocation of SREBPs.
  • Decreases transcription of lipogenic genes.
  • Exhibits antitumor properties.
  • Lowers hyperglycemia in ob/ob mice.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.